Lyme disease

Current Neurology and Neuroscience Reports

Volumn 2, Issue 6, 2002, Pages 479-487

  Coyle, Patricia K ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Babesiosis; Borrelia Burgdorferi; Lyme Borreliosis; Lyme Disease; Peripherally Insert Central Catheter

Indexed keywords

ANIMAL; BORRELIA BURGDORFERI; COMMUNICABLE DISEASE; ERYTHEMA CHRONICUM MIGRANS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LYME DISEASE; MICROBIOLOGY; NEUROLOGIC DISEASE; PATHOLOGY; REVIEW; TICK;

ANIMALS; BORRELIA BURGDORFERI; COMMUNICABLE DISEASES; ERYTHEMA CHRONICUM MIGRANS; HUMANS; IXODIDAE; LYME DISEASE; NERVOUS SYSTEM DISEASES;

EID: 0036831383     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-002-0033-2     Document Type: Article

References (61)

1. Shadick NA, Phillips CB, Logigian EL, et al.: The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 1994, 121:560–567.
2. Shapiro ED, Gerber MA: Lyme disease. Clin Infect Dis 2000, 31:533–542.
3. Silver HM: Lyme disease during pregnancy. Infect Dis Clin North Am 1997, 11:93–97.
4. Steere AC: Lyme disease. N Engl J Med 2001, 345:115–125.
5. Lin J, Oliver JH Jr, Gao L: Genetic diversity of the outer surface protein C gene of southern Borrelia isolated and its possible epidemiological, clinical, and pathogenetic implications. J Clin Microbiol 2002, 40:2572–2583.
6. Orloski KA, Hayes EB, Campbell GL, Dennis DT: Surveillance for Lyme disease—United States, 1992–1998. MMWR CDC Surveill Summary 2000, 49:1–11.
7. Fraser CM, Casjens S, Huang WM, et al.: Genomic sequence of a Lyme disease spirochete, Borrelia burgdorferi. Nature 1997, 390:580–586.
8. Babb K, El-Hage N, Miller JC, et al.: Distinct regulatory pathways control expression of Borrelia burgdorferi infectionassociated OspC and Erp surface proteins. Infect Immunol 2001, 69:4146–4153.
9. Stevenson B, Babb K: LuxS-mediated quorum sensing in Borrelia burgdorferi, the Lyme disease spirochete. Infect Immunol 2002, 70:4099–4105.
10. Elliott DJ, Eppes SC, Klein JD: Teratogen update: Lyme disease. Teratology 2001, 64:276–281. Reviews the data indicating low risk to the fetus in pregnant women exposed to Borrelia burgdorferi.
11. Wormser GP, Bittker S, Cooper D, et al.: Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease. J Clin Microbiol 2000, 38:1648–1650.
12. Nadelman RB, Wormser GP: Lyme borreliosis. Lancet 1998, 352:557–565.
13. Coyle PK, Schutzer SC: Neurologic aspects of Lyme disease. Med Clinic North Am 2002, 6:1–24. This is a good review article discussing Lyme disease, with an emphasis on neurologic involvement.
14. Finizia C, Jonsson R, Hanner P: Serum and cerebrospinal fluid pathology in patients with sudden sensorineural hearing loss. Acta Otolaryngol 2001, 121:823–830.
15. Logigian EL, Kaplan RF, Steere AC: Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990, 323:1438–1444.
16. Logigian EL, Kaplan RF, Steere AC: Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J Infect Dis 1999, 180:377–383.
17. Mantienne C, Albucher JF, Catalaa I, et al.: MRI in Lyme disease of the spinal cord. Neuroradiology 2001, 43:485–488.
18. Neophytides A, Khan S, Louie E: Subacute cerebellitis in Lyme disease. Int J Clin Pract 1997, 51:523–524.
19. Oksi J, Kalimo H, Marttila RJ, et al.: Intracranial aneurysms in three patients with disseminated Lyme borreliosis: cause or chance association? J Neurol Neurosurg Psychiatry 1998, 64:636–642.
20. Halperin JJ, Logigian EL, Finkel MF, Pearl RA: Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease).Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1996, 46:619–627.
21. Beitinjaneh F, Rizvi S, Coyle PK, Krupp LB: Diagnostic accuracy of serologic testing for Lyme disease. Neurology 2001, 56:A479.
22. Klempner MS, Schmid CH, Hu L, et al.: Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med 2001, 110:217–219.
23. Nocton JJ, Dressler F, Rutledge BJ, et al.: Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 1994, 330:229–234.
24. Nocton JJ, Bloom BJ, Rutledge BJ, et al.: Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 1996, 174:623–627.
25. Perides G, Charness ME, Tanner LM, et al.: Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. J Infect Dis 1998, 177:401–408.
26. Gomes-Solecki MJ, Wormser GP, Persing DH, et al.: A first-tier rapid assay for the serodiagnosis of Borrelia burgdorferi infection. Arch Intern Med 2001, 161:2015–2020.
27. Marques AR, Martin DS, Philipp MT: Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine. J Clin Microbiol 2002, 40:2591–2593.
28. Halperin JJ: Nervous system Lyme disease. J Neurol Sci 1998, 153:182–191.
29. Brunner M, Sigal LH: Use of serum immune complexes in a new test that accurately confirms early Lyme disease and active infection with Borrelia burgdorferi. FJ Clin Microbiol 2001, 39:3213–3221.
30. Schutzer SE, Coyle PK, Reid P, Holland B: Borrelia burgdorferispecific immune complexes in acute Lyme disease. JAMA 1999, 282:1942–1946.
31. Seinost G, Dykhuizen DE, Dattwyler RJ, et al.: Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immunol 1999, 67:3518–3524.
32. Albisetti M, Schaer G, Good M, Boltshauser E, Nadal D: Diagnostic value of cerebrospinal fluid examination in children with peripheral facial palsy and suspected Lyme borreliosis. Neurology 1997, 49:817–824.
33. Belman AL, Reynolds L, Preston T, et al.: Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy. Arch Pediatr Adolesc Med 1997, 151:1224–1228.
34. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ: Treatment of late Lyme borreliosis—randomised comparison of ceftriaxone and penicillin. Lancet 1988, 1:1191–1194.
35. Coyle PK: Neurologic Lyme disease. In Current Therapy and Neurologic Disease, edn 6. Edited by Johnson RT, Griffin JW, McArthur JC. St. Louis: Mosby; 2001:159–164.
36. Schutzer SE, Brown T Jr, Holland BK: Reduction of Lyme disease exposure by recognition and avoidance of high-risk areas. Lancet 1997, 349:1668.
37. Schutzer SE, Holland BK, Brown T Jr: Avoidance of tick-borne diseases. Ann Intern Med 1998, 128:784.
38. Sood SK, Salzman MB, Johnson BJ, et al.: Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic. J Infect Dis 1997, 175:996–999.
39. Nadelman RB, Nowakowski J, Fish D, et al.: Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001, 345:79–84.
40. Steere AC, Sikand VK, Meurice F, et al.: Vaccination against Lyme disease with recombinant Borrelia burgdorferi outersurface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 1998, 339:209–215.
41. Hsia EC, Chung JB, Schwartz JS, Albert DA: Cost-effectiveness analysis of the Lyme disease vaccine. Arthritis Rheum 2002, 46:1651–1660. This decision-analysis model found that Lyme disease incidence had to exceed 10% before vaccination becomes cost effective for residents of endemic regions with frequent tick exposure.
42. Akin E, McHugh GL, Flavell RA, et al.: The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immunol 1999, 67:173–181.
43. Hirschfeld M, Kirschning CJ, Schwandner R, et al.: Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999, 163:2382–2386.
44. Maimone D, Villanova M, Stanta G, et al.: Detection of Borrelia burgdorferi DNA and complement membrane attack complex deposits in the sural nerve of a patient with chronic polyneuropathy and tertiary Lyme disease. Muscle Nerve 1997, 20:969–975.
45. Akin E, Aversa J, Steere AC: Expression of adhesion molecules in synovia of patients with treatment-resistant lyme arthritis. Infect Immunol 2001, 69:1774–1780.
46. Cadavid D, O’Neill T, Schaefer H, Pachner AR: Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease. Lab Invest 2000, 80:1043–1054.
47. Roberts ED, Bohm RP Jr, Lowrie RC Jr, et al.: Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis 1998, 178:722–732.
48. Pachner AR: The rhesus model of Lyme neuroborreliosis. Immunol Rev 2001, 183:186–204.
49. Pachner AR, Cadavid D, Shu G, et al.: Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis. Ann Neurol 2001, 50:330–338.
50. Thompson C, Spielman A, Krause PJ: Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis. Clin Infect Dis 2001, 33:676–685.
51. Krause PJ, Telford SR, Spielman A, et al.: Concurrent Lyme disease and Babesiosis. Evidence for increased severity and duration of illness. JAMA 1996, 275:1657–1660.
52. Thomas V, Anguita J, Barthold SW, Fikrig E: Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immunol 2001, 69:3359–3371.
53. Krause PJ, Spielman A, Telford SR, et al.: Persistent parasitemia after acute babesiosis. N Engl J Med 1998, 339:160–165.
54. Krause PJ, Lepore T, Sikand VK, et al.: Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med 2000, 343:1454–1458.
55. Dumler JS, Bakken JS: Human ehrlichioses: newly recognized infections transmitted by ticks. Annu Rev Med 1998, 49:201–213.
56. Leyssen P, De Clercq E, Neyts J: Perspectives for the treatment of infections with Flaviviridae. Clin Microbiol Rev 2000, 13:67–82.
57. Chang CC, Chomel BB, Kasten RW, Romano V, Tietze N: Molecular evidence of Bartonella spp. in questing adult Ixodes pacificus ticks in California. J Clin Microbiol 2001, 39:1221–1226.
58. Hofmeister EK, Kolbert CP, Abdulkarim AS, et al.: Cosegregation of a novel Bartonella species with Borrelia burgdorferi and Babesia microti in Peromyscus leucopus. J Infect Dis 1998, 177:409–416.
59. Schouls LM, Van De Pol I, Rijpkema SG, Schot CS: Detection and identification of Ehrlichia, Borrelia burgdorferi sensu lato, and Bartonella species in Dutch Ixodes ricinus ticks. J Clin Microbiol 1999, 37:2215–2222.
60. Asch ES, Bujak DI, Weiss M, et al.: Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 1994, 21:454–461.
61. Seltzer EG, Gerber MA, Cartter ML, et al.: Long-term outcomes of persons with Lyme disease. JAMA 2000, 283:609–616.